Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2010 by University Hospital, Bonn.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
University Hospital, Bonn
ClinicalTrials.gov Identifier:
NCT00126321
First received: August 2, 2005
Last updated: February 1, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)